A Chinese company has successfully developed a new anti-malarial drug, Artequick, and has begun testing its efficacy in the Comoros, a three-nation island with a long history of the parasite. Early positive results have excited researchers for the new medications’ ability to rid malaria in a host’s body, rather than target mosquitos.